Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours

pharmatimesAugust 06, 2021

Tag: sativex , brain tumours , UK , glioblastoma

PharmaSources Customer Service